Such studies were logical also due to the fact that increased serum levels of IFN had been reported in samples from patients with SLE (20, 21), although it was difficult to determine if the IFN was type I or type II IFN from the beginning. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.